[{"address1": "700 Chesapeake Drive", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 364 0400", "website": "https://pulmonx.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.", "fullTimeEmployees": 279, "companyOfficers": [{"maxAge": 1, "name": "Mr. David A. Lehman", "age": 62, "title": "General Counsel & Secretary", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 651389, "exercisedValue": 0, "unexercisedValue": 19287}, {"maxAge": 1, "name": "Mr. Geoffrey Beran Rose", "age": 49, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 632293, "exercisedValue": 0, "unexercisedValue": 1090593}, {"maxAge": 1, "name": "Mr. Steven S. Williamson", "age": 50, "title": "CEO, President & Director", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mehul  Joshi", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sri  Radhakrishnan", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Marcee M. Maroney", "age": 53, "title": "Vice President of Marketing", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sarah  Huber", "title": "Vice President of Sales (U.S.)", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Paul", "age": 59, "title": "Chief People Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. J\u00e9r\u00f4me  Erath", "title": "Senior VP & GM of Europe Middle-East & Africa", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John B. McKune", "age": 47, "title": "VP & Corporate Controller", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1724803200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.32, "open": 7.34, "dayLow": 7.22, "dayHigh": 7.42, "regularMarketPreviousClose": 7.32, "regularMarketOpen": 7.34, "regularMarketDayLow": 7.22, "regularMarketDayHigh": 7.42, "beta": 0.622, "forwardPE": -4.5185184, "volume": 111789, "regularMarketVolume": 111789, "averageVolume": 348460, "averageVolume10days": 275350, "averageDailyVolume10Day": 275350, "bid": 7.28, "ask": 7.34, "bidSize": 200, "askSize": 400, "marketCap": 286597024, "fiftyTwoWeekLow": 5.46, "fiftyTwoWeekHigh": 14.835, "priceToSalesTrailing12Months": 3.742306, "fiftyDayAverage": 6.8438, "twoHundredDayAverage": 9.3981, "currency": "USD", "enterpriseValue": 228239680, "profitMargins": -0.75556, "floatShares": 37477998, "sharesOutstanding": 39152600, "sharesShort": 1451224, "sharesShortPriorMonth": 1289294, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.037100002, "heldPercentInsiders": 0.05232, "heldPercentInstitutions": 0.94241, "shortRatio": 3.96, "shortPercentOfFloat": 0.052699998, "bookValue": 2.584, "priceToBook": 2.8328173, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -57863000, "trailingEps": -1.5, "forwardEps": -1.62, "pegRatio": -0.22, "enterpriseToRevenue": 2.98, "enterpriseToEbitda": -4.009, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "LUNG", "underlyingSymbol": "LUNG", "shortName": "Pulmonx Corporation", "longName": "Pulmonx Corporation", "firstTradeDateEpochUtc": 1601559000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e6c2e6bc-5375-39f3-b953-9a49b1ec8ea8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.32, "targetHighPrice": 17.0, "targetLowPrice": 10.0, "targetMeanPrice": 14.0, "targetMedianPrice": 14.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 114545000, "totalCashPerShare": 2.926, "ebitda": -56929000, "totalDebt": 56188000, "quickRatio": 7.75, "currentRatio": 8.966, "totalRevenue": 76583000, "debtToEquity": 55.531, "revenuePerShare": 1.988, "returnOnAssets": -0.20251, "returnOnEquity": -0.49216998, "freeCashflow": -17661624, "operatingCashflow": -34640000, "revenueGrowth": 0.209, "grossMargins": 0.74186, "ebitdaMargins": -0.74336, "operatingMargins": -0.75167, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-01"}]